[1]
Nalli, C., Andreoli, L., Motta, M., Norman, G., Shums, Z., Binder, W., Nuzzo, M., Frassi, M., Lojacono, A., Meini, A., Medeghini, V., Avcin, T., Meroni, P. and Tincani, A. 2011. Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1. Reumatismo. 63, 2 (Jun. 2011), 91–96. DOI:https://doi.org/10.4081/reumatismo.2011.91.